Interview with Murtaza Khorakiwala, Managing Director, Wockhardt
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
Address: W-199-E, MIDC Khairne, Thane Belapur Road,Navi Mumbai – 400705.,India
Tel: +91-22-4151 5151
Web: http://www.nilsan-nishotech.com/
The Company Started in 1989 as a PROCESS ENGINEERING COMPANY & is today one of the most accomplished and diversified business houses in India having head office in Mumbai , branch office at Hyderabad. At NILSAN Nishotech we have two SBU’S SEPTECH & EPMG. The Group’s success has been driven by the company’s commitment to delivering innovation and excellence. Through the consistent application of this commitment and a century of ethical business conduct, Nilsan Nishotech has earned an unparalleled reputation for trust a,nd reliability.
In 23 years, NILSAN Nishotech is the first company in India to develop the technology to support Pharma, Bio-Pharma , Sugar , Food & Healthcare customers; this spirit of innovation has continued throughout the organization’s history. Today NILSAN Nishotech is delivering exciting engineering innovative solutions across a spectrum of businesses. The company’s pursuit of excellence is equally well established and enduring. NILSAN Nishotech’s management understands that the company’s greatest asset is the trust and faith that customers have reposed in it, and recognizes that the company must continue to earn this trust. This translates to the organization delivering outstanding quality and value in everything it does. We have Overseas association with French Company Novasep (Chromatography Columns) , Austar –China (RO+EDI Skid) , Ziemann –India (Tanks) , DrM – Switzerland (Candle Filtration System) for which we stand one point contact in India.
Sterile Process Piping, Separation Technologies, Pharma Water Technologies
You joined Wockhardt in 2000; you became a member of the board in 2006, and were appointed managing director in 2009. The Indian industry has undergone many changes in the…
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully complete Phase III trials, and you are readying to release it…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Since we last met in 2006, the Indian pharmaceutical industry has been doing very well indeed, as a very large number of drugs came off patent. This trend will continue…
Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been…
“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we are on our way to become a R&D hub.” For Dilip Shah, General…
See our Cookie Privacy Policy Here
